Tagrisso was linked to higher cardiac risks in patients with EGFR-mutant NSCLC, including a four-fold rise in cardiac events ...

John Geddes (L) with the crew of the mobile coronary care unit Personal collection of Sam Webb John Geddes was working as a registrar in the cardiology unit of the Royal Victoria Hospital in Belfast ...

Patients with EGFR-mutated non-small cell lung cancer treated with osimertinib experienced more cancer therapy-related ...

"Later that day, I had a phone call to say that I had had a heart attack and that they were expecting me in A&E. I spent five ...

Consecutive patients with ST-elevation myocardial infarction (STEMI ... Therapy consisted of ATP followed by shock. Ventricular arrhythmia that did not reach the set number of detection intervals ...

Learn about common heart conditions like Hypertrophic Cardiomyopathy and Channelopathies that can lead to unexpected cardiac events in younger demographics.

Patients are significantly more likely to experience treatment-related cardiac events with osimertinib than with other EGFR TKIs, data suggest.

Jamie B. Conti, M.D., F.A.C.C.; C. Richard Conti, M.D., M.A.C.C. Jamie B. Conti, M.D., F.A.C.C. Assoc Prof of Medcn, Shands Hospital University of Florida C. Richard ...

Explore the latest innovations in cardiogenic shock treatment, including advances in mechanical circulatory support devices, ...

Heart health is central to overall well-being, so it's important to be aware of certain risk factors for heart disease and symptoms that may indicate something is wrong ...

AI-enabled ECG biological age (ECG-BA) improves disease risk classification beyond chronological age, enhancing early ...

Doctor highlights underestimated heart risks of PM2.5 pollution, urging precautions like mask-wearing and avoiding outdoor ...